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Objectives. This study was undertaken to investigate the role of 
endothelium-derived nitric oxide in the regulation of forearm 
blood flow during exercise in normal subjects and patients with 
congestive heart faiiure. 
Baclsgro~~I. Nitric oxide-mediated vaasodilation i  response to 
muscarinic stimulation is impaired in the peripheral circulation 
of patients with congestive heart failure. whether nitric oxide- 
mediated vaaodilation during exercise is also impaired in patients 
with congesr;ive heart failure is unknown. 
Jfe&ak Forearm blood flows (mUmin per 100 ml) were 
determined during rhythmic hand grip exercise at 15%, 3@% and 
45% of maximal v&mtary contr;Pdion by venous occlusion pieth- 
ysmography before and after regional inhibition of nitric oxide 
synthesis with administration of L-P-monomethylarginine (L- 
NMMA) in the brachial artery of 17 patients with congestive heart 
failure (mean age 49 years, mean left ventricular ejection fraction 
Q.22) and 10 age-matched normal subjects. 
Results. Before administration of t-NMMA in the brachial 
artery, forearm blood flows in patients with congestive heart 
failure during rhythmic hand grip exercise at 15%, 38% and 45% 
of maximal voluntary contraction were slightly but not signifi- 
cant!y lower than that ofoirrmal subjects ([mean 9 SE] 6.8 -C I.@, 
8.5 -C 1.0 and 22.9 + 1.7 mUmin per LOO ml, respectively, in 
patients with congestive heart failure vs. 6.6 5~ L&11.6 + 1.9 and 
16.2 r?: 1.9 mUmin per 100 ml, respectively, in normal subjects, p = 
NS). After administration of L-NMMA in the bra&al artery, 
forearm blood flows in normal subjects significantly deePeased by 
IQ% to 21% during hand grip exercise but did not change during 
exercise in patients with congestive heart failarz. 
Con&&s. Regional inhibition of nitric oxide synthase with 
administration of L-N~MMA in the hrachial artery signifiaetly 
decreased forearm blood flows during rhythmic band grip exercise 
in normai subjects but not in patients tiih congestive heart 
failure. These findings suggest that nitric oxide-medial+ vasodi- 
lation doring submaximal exercise is impaired in the forearm 
circulation of patients with congestive heart failure. 
(J Am Coil Gdiol1996;28:58.5-912) 
Vascular endothelial cells synthesize nitric oxide from 
L-arginine in response to a diverse array of hormonal, chemical 
and physical stimuli (1,2). Nitric oxide is a potent vasodilating 
substance that appears to play an important role in modulating 
the vascular smooth muscle response to hormonal agonists and 
in regulating peripheral vasomotor tone at rest and during 
exercise in response to local changes in endothelial cell mem- 
brane shear stress produced by pulsatile blood flow (3,4). 
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In patients with congestive heart failure, agonist-induced 
nitric o.xide-mediated vasodilation in response to muscarinic 
stimulation is impaired in the peripheral and coronary cir- 
culations (S-7). In contrast, there is evidence that basal release 
of nitric oxide may be normal or increased in patients with 
congestive heart failure compared with that in normal sub- 
jects (8-10). The role of nitric oxide in the regulation 
of peripheral vasomotor tone in response to exercise has 
not yet been characterized in patients with congestive heart 
failure. 
Accordingly, the present study was undertaken to investi- 
gate nitric oxide-mediated vasodilation at rest and during 
exercise in normal subjects and patients with congestive heart 
failure. Forearm blood Aorv was determined with strain gauge 
venous occlusion pIethysmogra~hy at rest and during rhythmic 
hand grip exercise before and after i&!bition of n,itric oxide 
synthesis with administration of a sub%ltuted arginiqe analog 
L-p-monomethytarginine (L-NMMA) in the brachiat artery 
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Methods 
Study patients. Sixteen men and one woman with chronic 
congestive heart failure participated in the study imean age 
j?SD] 49 ? 11 years, range 32 to 65). The mean left 
ventricular ejection fraction determined by radionu:lide an- 
giography was 22%. The etiology of left ventricular dysfunction 
was idiopathic di!ated carfilomyopathy in 14 patients, alcchol- 
related cardiomyopathy in 2 and adriamycin-related cardiomy- 
opathy in 1. All patients had a history of symptomatic conges- 
tive heart failure and were clinically stable for at least 4 weeks 
before the study. Four patients were in New York Heart 
Association functional class I; g were in class Ii, and 5 were in 
class III. Cardiovascular medications, which included diuretic 
drugs, angiotensin converting-enzyme inhibitors and digaxin in 
all patients, were withheld for 24 h before the study. Patients 
with peripher;: edema; serum sodium ~136 mEq./Iiter; or 
history of diabetes mellitus, hypertension or hypercholrsterol- 
emia were excluded from the study. 
Nine men and one woman without history of chronic 
medical illness participated as normal control subjects (mean 
age 43 c 13 years, range 27 to 66, not statistically different 
from patients with congestive heart failure). The control 
subjects were nonsmokers, had normal results on the physical 
examination and were not taking medications. The study was 
approved by the ethical review board of the Columbia Presby- 
terian Medical Center. All patients and normal subjects gave 
written informed consent before the study. 
Yeaous occlusion plethysmography. Forearm blood flow 
(mlimin per 100 ml of forearm volume) was determined with 
venous occlusion strain gauge plethysmography, as previously 
described in detail (12). Briefly, with the arm resting comfort- 
ably 10 cm above the right atrium, a mercury-in-Silastic strain 
gauge was placed around the widest portion of the upper third 
of the forearm. The strain gauge was electrically coupled to a 
plethysmograph (Parks Electronics) calibrated to measure 
percent change in volume. The plethysmographic tracings of 
forearm blood flow were digitally recorded on a personal 
computer at 40 Hz for later analysis (Mac1 ah Software). For 
each measurement, forearm venous blood flow was occluded 
just proximal to the elbow with the rapid inflation of a blood 
pressure cuff to 40 mm Hg (Hokanson Instruments, model E 
20). A wrist cuff was inflated to suprasystolic pressures 1 min 
before and during each measurement to exclude the hand 
circulation from the blood flow determination. The venous 
occluding cuff was inflated for 5 s at 15-s intervals; five 
plethysmographic measurements were averaged for determi- 
nation of forearm blood flow -It rest and during the last minute 
of each level of rhythmic hand grip exercise, 
Rhythmic hand grip exercise protocot. Rhythmic hand grip 
exercise was performed according to the protocol previously 
reported by Longhurst et al. (13). Study subjects rhythmically 
squeezed a hand dynanometer in 15-s cycles that consisted of 
5 s of steady hand grip pressure alternating with 10 s of rest. 
Three levels of exercise, corresponding to 15%, 30% and 45% 
of a previously determined maximal voluntary contraction 
were each performed for 3 min. Mean maximal voluntary 
contraction was similar in patients with congestive heart failure 
and normal subjects (15.5 ? 1.1 vs. 18.1 + 1.5 psi, respectively, 
p = NS). Forearm blood flow was determined in the last 
minute of exercise during the S-s period of each rest cycle 
immediately before the next hand grip contraction. 
Drug preparation. r,-fl-Monomethylarginine (L-NMMA) 
(Sigma Chemical Co.), a competitive inhibitor of nitric oxide 
synthase, was prepared as a sterile, pyrogen-free solution in 
5% dextrose in water and was administered as a continuous 
I-ml/min infusion for 5 min at a dose of 4 X lo-” moljliter. 
This dose of L-NMMA has previously been demonstrated to be 
effective in inhibiting nitric synthase activity in isolated vascu- 
lar tissue and in the intact human forearm circulation (1 I ,14). 
Study protocol, Subjects were studied in the postabsorptive 
s&ate whiie resting in the supine position in a quiet, 
temperature-cosli,......,,, :. r?l room. To exclude the effects of pros- 
taglandins on exe&se-induced vasodilation, all subjects re- 
ceived 50 mg of indomethacin, a cyclooxygenase inhibitor, by 
mouth 1 h before the study (15). A 20”gauge angiocathetheter 
was placed in the brachial artery of the nondominant forearm 
under local anesthesia for regional drug administration. After 
brachial artery catheterization was completed, subjects rested 
for 1 h before measurements were made. Forearm blood flows 
were measured during supine rest and during rhythmic fore- 
arm hand grip exercise at lS%, 30% and 45% of maximal 
voluntary contraction. After completion of this sequence of 
forearm blood flow measurements, L-NMMA was adminis- 
tered into the brachial artery as a 5-min continuous infusion 
during supine rest. The sequence of forearm blood flow 
measurements at rest and during graded hand grip exercise 
was repeated immediately after completion of the intraarterial 
infusion of L-NMMA. Mean arterial pressure was recorded at 
I-min intervals throughout the study with an automated cuff 
method (Critikon Inc.). 
To determine the reproducibility of the measurements of 
forearm blood flow during exercise, rhythmic hand grip exer- 
cise at IS%:, 30% and 45% was performed by an additional five 
normal subjects and five patients with congestive heart failure 
twice at a 30-min intervbi VJiihout other intervention. Forearm 
blood Ilow measurements during exercise were unchanged 
over time in both normal subjects and patients with congestive 
heart failure (Table 1). 
Determination of peak oxygen uptake. To determine the 
relation of regional vascular responses to administration of 
L-NMMA with peak aerobic capacity, all but one patient with 
congestive heart failure performed a symptom-limited maxima1 
exercise test on a motorized treadmill within 1 month of the 
forearm blood flow measurements. Peak oxygen uptake was 
determined by analysis of expired gases (SensorMedics) as the 
highest 20-s average value obtained in the last minute of 
exercise when the respiratory exchange ratio was >l.lO, 
Data analysis. All results are mean value + SE. Forearm 
blood flows and mean arterial pressures in patients with 
congestive heart failure and normal subjects at rest, during 
exercise and during administration of acetylcholine and nitro- 
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Table 1. Reproducibility of Forearm Blood Flow Measuremeuts at 
Rest and in Response to Hand Grip Exercise 
F’ore:arm B!ood Flow (mlimin per ml) 
___- - 
Patients With CHF 
Nomu Subjects (n = 5) (n = 5) 
Baseline 30 min Baseline 30 niin 
Rest 1.8 2 0.2 2.0 I?: 0.3 1.6 of- 0.3 1.7 ?c 0.3 
15% MVC 5.9 2 0.9 25 2 0.5 6.8 t 0.9 6.6 -t 1.1 
30% MVC 10.4 -t 1.7 10.2 Y! 1.3 lO.r? + 2.0 11.0 t 2.0 
45% MVC 11.4 + 2.6 14.0 t 2.1 14.6 i 2.2 14.0 t 2.1 
Data presented are mean value t SE. CHF = congestive heart failure; 
MVC = maximal voluntary contraction. 
glyceriil were compared before and after administration of 
L-.NlvlMA with a repeated measures analysis of variance model 
that consisted of one between-group factor (normal subjects vs. 
patients with heart failure) and two within-group factors (rest 
and three levels of exercise before and after administration of 
L-NWINiA). Correlations between ccntinuous variables of in- 
terest were analyzed with simple linear regression. A hvo- 
tailed probability value co.05 was considered statistically 
significant. 
Results 
Effects I$ L-M~ on rest forearm blood flow. Before 
administration of L-NMMA in rhe brachial artery, rest forearm 
blood Aows were similar in normal subjects and in patients with 
congestive heart failure (2.8 5 0.3 vs. 2.3 + 0.3 mUmin per 100 ml, 
respectively). After administration of L-PJMMA in the brachial 
artery, rest forearm blood flow significantly decreased by 25% 
in normal subjects but did not change in patients with conges- 
tive heart failure (Fig. 1). 
Figure 1. Mean rest forearm blood flows in 10 normal subjects and Z7 
patients with congestive heart failure (CHF) before (salid columns) 
and after {open columns) administration of L-NMMA in the brdchiai 
artery. *p < 0.03 versus before I.-NMMA. 
i 
* 
It 
- 
Normals 
25% MWC 30% MVC 45% MVC 
0' , I 1 
1% WC 30% MVC 45% MVG 
Figure 2. Mean forearm blood Rows during &thmic hand grip 
exercise at 1595, 30% and 35% of maximal voluntary contraction 
(NV&) in 10 normal subjects (A) and 17 patients with congestive heart 
failure (B) before (open squares) and after administration of 
L-NMMA in the brachial artery @*lid squares:k *p < 0.05 versus 
before L-NMMA. 
Elf& of L-NW on forearm i&uJd Row respunse to rbytll- 
mic hand grip exercise. Before administration of L-NMhIA in 
the brachial artery, forearm blood flows in patients with 
congestive heart failure during rhythmic hand grip exercise at 
15%, 30% and 45% of maximal voluntary contraction were 
slightly but not significantly !ower than that in normal subjects 
(6.X IC 1.0, 8.5 XL 1.0 and 12.9 ?z 1.7 mlimin per 100 ml, 
respectively, in patients with congestive heart failrze vs. 6.6 IT 
1.2,11.6 4 1.9 and 16.2 3- 1.9 mUmin per 100 ml, respectively, 
in normal subjects, p = NS). After administra:ion of L-NMMA 
in the brachiai artery, forearm blood flows during rhythmic 
hand grip exercise signiticantly decreased in normal subjects at 
each level of exercise by 21%., 17% and IO%, respectively {all 
p < 0.0.5 vs. before L-NMMA values) (Fig. 2Aj but did not 
chaqge in patients with congestive heart fai?ure (Fig. 2B), 
Fbysiologic correlates of mpodse to L-NM In patients 
with congestive heart failure, the dzcreasr: io rest forearm 
blood flow in response to administration of L-NMMA was 
signiftcantly correlated with both baseline rest forearm blood 
flc~ and peak o.xygen uptake attained during treadmill exerejse 
{r = 0.72 and 0.73, respectively? both p < 0.01) (Fig. 3)‘ 
588 KATZ ET Al.. 
NITRIC OXIDE DLJR!NG MEkCISE IN HEART FAILURE 
JACC Vol. 28, No. 3 
September 1996:585-90 
Resting Forearm Blood Flow 
(ml/ininflOO ml) 
2 : 
z 2 1 
tii 
%= 
50 E 0 
iig 
82 
OE 
-1 
sii‘ 
E 
.r - 
i% -2 
2 0 
6 -3 
5 10 15 20 25 30 35 
Peak Oxygen Uptake 
(ml/min/kg) 
Figure 3. Changes in rest forearm blood flow in response to adminis- 
tratio:l of L-NMMA as a function of initial rest forearm blood flow (A) 
and peak oxygen uptake (B). 
Effects of L-NMM.4 II mean arterial pressure. Before 
administration of L-NMMA in the brachial artery, mean 
arterial pressures at rest were similar in normal subjects and 
patients with congestive heart failure. During hand grip exer- 
cise, mean arterial pressure increased slightly in both normal 
subjects and patients with congestive heart failure. After 
administration of I.-NMMA in the brachial artery, mean 
arterial pressures at rest and &using hand grip exercise did not 
change in either normal subjects or patients with congestive 
heart failure (Table 2). 
Discussion 
The present data demonstrate that regional inhibition of 
nitric oxtde synthase with administration of L-NMMA in the 
brachial artery significantly decreased forearm blood flows at 
rest and during rhythimic hand grip exercise in normal subjects 
but not in patients with congestive heart failure. These findings 
suggest that nitric oxide-mediated vasodilation at rest and 
during submaximal exercise is impaired in the forearm circu- 
lation of patients with congestive heart failure. 
Effects of L-NMMA during exercise in narmal subjects. 
Regional inhibition of nitric oxide synthase with L-NMMA 
decreased the forearm blood flo-ws during rhythmic hand glip 
exercise by iO% 10 21% in normal subjects. Previous studies of 
the effects of nitric oxide synthase inhibition with L-NMMA on 
exercise-induced hypere&a in normal subje;::s have yielded 
conflicting findings. Gilligan et al. (16) and Endo et al, (17) 
reported rediictions in forearm blood Aow during exercise in 
response to administration of L-NMMA in normal subjects 
that were comparable to those observed in the current study. 
Tn contrast, Wilson and Kapoor (18) reported no change in 
exercise hyperemia after administration of L-NMMB in nor- 
mal subjects. The current findings provide evidence that the 
regional vasodiiatory response during exercise is partly medi- 
ated by nitric oxide-dependent mechanisms. Increased shear 
stress at the endothelial cell lumen surface appears to be an 
important physiologic stimulus of endothelial nitric oxide 
synthesis during exercise. Shear stress at the endothelial cell 
surface has been demonstrated to be a potent stimulus of 
endothel’al cell nitric oxida synthesis in endothelial cell culture 
and isolated vascular rings (19-2.2). In rats, systemic inhibition 
of nitric oxide synthase during exercise with the arginine 
analog RiG-L-arginine methyl ester (L-NAME) significantly 
reduced blood flow to muscles with a high percentage of 
oxidative fibers but did noi change blood flow to muscles with 
a high percentage of glycolytic fibers (4). These findings 
suggest that nitric oxide contributes to the regulation of 
skeletal muscle blood flow as part of a coordinated system that 
preferentially supplies blood flow to oxidative muscles during 
submaximal exercise. These findings may account for the 
apparent attenuation of the effects of L-NMMA on forearm 
blood flow in normal subjects at the higher exercise work rates 
in the present study. At low work rates, when oxidative muscle 
fibers arc selectively recruited, shear stress-induced nitric 
Table 2. Effects of Administration of on Mean Arterial Pressure at 
Rest and During Rhythmic Hand Grip Exercise in 10 Normal 
Subjects and 17 Patie:& With Congestive Heart 
Mean Arterial Pressure (mm Hg) 
Before L-NMMA After L-NMMA 
(mean i SE) (mean 2 SE) 
Rest 
Normal subjects 
Pts with CHF 
15% MVC 
Norma! subjects 
Pts with CHF 
30% MVC 
Normal subjects 
Pts with CHF 
45% MVC 
Normal subjects 
Pts with CHF 
9124 89 t 4 
89 2 4 87 t 4 
90 2 5 
9124 
9125 
92 -t 4* 
92 i 5 
90 It 4” 
94 i- 4T 
91+4* 
93 2 4t 
92 2 ‘I* 
*p d 0.05 versus rest value in patients (Pts) with congestive heart failure 
(CHF). tp < 0.05 versus rest value in normal subjects. L-NMMA = L-I@- 
monomethyiarginine; MVC = maximal voluntary contraction. 
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oxide-mediated vasodilation may increase regional blood flow 
to oxidative fibers by augmenting mild iocaf metabolic vasodi- 
Iation mechanisms. At higher work rates, when a greater 
proportion of glycolytic muscle fibers are recruited, shear 
stress-induced nitric oxide-mediated vasodilation may contrib- 
ute less to the overall vasodilation response as intense local 
metabolic vasodilation mechanisms are activated. The recent 
finding (23) that administration of L-NMMA does not alter 
peak hyperemic forearm blood flow after IO min of arterial 
occlusion in normal subjects is consistent with this interpreta- 
tion of the data. 
Effects of L-NMMA during exe&e in patients with heart 
failure. in contrast to normal subjects, regional inhibition of 
nitric oxide synthase with L-DiMMA did not change blood lIow 
during rhythmic hand grip exercise in patients with congestive 
heart failure. The current findings are in agreement with a 
previous study (24) of experimental heart failure in the rat, in 
which exercise-indtrced nitric oxide-mediated vasodilation in 
skeletal muscle circulation of the hind limb was significantly 
attenuated in rats with large myocardial infarction compared 
with that in rats with small myocardial infarction and sham- 
operated control rats. The current data also extend the findings 
of previous studies in patients with congestive heart failure that 
demonstrated decreased agonist-induced nitric oxide- 
mediated vasodilation in response to muscarinic stimulation in 
the forearm circulation of patients with congestive heart 
failure compared with that of rbrmal subjects (5,6). Because 
the endothelium-dependent niti.+z oxide-mediated vasodila- 
tion during exercise m,ay be 5duced by shear stress at the 
endothelial cell lumen surface, both shear stress-induced and 
agonist-induced endothelial nitric oxide production appear to 
be impaired in patients with congestive heart failure. Because 
shear stress and muscarinic receptor stimulation increase 
intracellular calcium and thereby regulate activity of nitric 
oxide synthase by different upstream signal transduction path- 
ways (29, the current findings suggest that the mechanisms 
contributing to decreased nitric oxide-mediated vasodilation 
in patients with congestive heart failure may be related to 
downstream abnormalities in idracellular calcium homeosta- 
sis, altered regulation of the activity of nitric oxide synthase or 
increased degradation of nitric oxide. Forearm blood flows 
during rhythmic hand grip exercise in the patients with heart 
failure tended to be lower but were not significantly decreased 
compared with that in normal subjects. This finding is in 
agreement with previous studies that demonstrated that fore- 
arm blood flows in response to submaximal exercise and other 
metabolic vasodilating stimuli are reduced only in patients with 
severe heart failure (26-30). Since nitric oxide-mediated va- 
sodilation during exercise was decreased in our patients, other 
compensatory vasodilatory mechanisms may have acted to 
maintain forearm blood flow during submaximal exercise in 
patients with congestive heart failure. 
Efkets of L-NMMA at rest. Administration of L-NMMA 
decreased rest forearm blood flow in normal subjects but not in 
patients with congestive heart failure in the current study. 
These findings are in accord with the majority of previous 
experimental studies that demonstrated impaired basal nitric 
oxide synthesis in isolated vascular rings and the intact circu- 
lation of animals with congestive heart failure compared with 
!hat in control animals (31-34). However, the current findings 
contrast two previous studies that demonstrated that adminis- 
tration of L-EMMA reduced rest blood flow in patients with 
congestive heart failure and normal subjects to a similar extent 
(8,9). The differences between the findings of these previous 
clinical studies and the current data may be related to differ- 
ences in tbe severity of disease in the study cohorts. Both the 
current study and the previous report by Kubo et al. (9) 
demonstrated a significant correlation between the decrease in 
rest forearm blood flow in response to administration of 
L-NMMA and the basal rest forearm blood flow. The rest 
forearm blood flows in patients with heart failure in the current 
study cohort were somewhat lower than those reported by 
Kubo et al. (9). The decrease in rest forearm blood flow in 
response to administration of L-NMMA was also significantly 
correlated with peak oxygen uptake determined during tread- 
mill exercise in the current study. This finding is in agreement 
with previous studies in anima! models of congestive heart 
failure ani! in patients sith congestive heart failure that 
demonstrated that abnormi:Iities of endothelial-dependent va- 
sodilation are most evident in advanced heart failure (24,34- 
36). 
Limitations of the study. Interpretation of the findings of 
the currem &dy is potentially confounded by the actions of 
vasoaciive factors other than nitric oxide that contribute to the 
regulation of skeletal muscle blood flow during exercise (37). 
Inhibition of nitric oxide synthesis may increase form&ion of 
other vasodilating factors by decreasing blood flow to active 
muscle fibers and by direct effects on mitochondrial function 
that may alter local concentrations of v?asodilatory metabolites 
in skeletal muscle (38). Azcause [additional nitric mide- 
independent vasodilatory mecham:ms may have been re- 
cruited during inhibition of n,;ric oxide synthase, it is possible 
that the current findings underestimate the effects of nitric 
oxide in the reg4ation of exzrcise-induced hyperemia. 
Whether impaired exercise-induced nitric oxide synthesis con- 
tributes to reduced aerobic capacity during exercise of the 
lower extremities in patients with congestive heart failure 
cannot be determined from the present study. In normal’ 
human subjects, Leaf et al. (39) demonstrated that sustained 
exercise with the lower extremities was associated with in- 
creased metabolic activity of tbe t,-arginine-nitric oxide path- 
way. 
Conclusions. Regional inhibition of nitric oxide synthase 
with administration of L-NMMA in the brachial artery signif- 
icantly decreased forearm blood flows at rest and during 
rhythmic hand grip exercise in normai subjects but not in 
patients with congestive heart failure. These findings suggest 
that endothelium-dependent nitric oxide-mediated vasodila- 
tion at rest and during submaximal exercise is impaired in the 
forearm circulation of patients with congestive heart failure ; 
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